MDMA-Supported Study Provides Powerful Evidence Of FDA Regulatory Challenges


For many in the life sciences industry, the regulatory approval process of the U.S. Food and Drug Administration (FDA) lacks predictability and transparency when it comes to product development. This lack of predictability and transparency directly translates into added costs for companies seeking regulatory approval of products and delay in time to market, which ultimately has an adverse impact on innovation, patient care, and jobs. Until now, this position has only been supported by anecdotal evidence.

With the help of industry, including Wilson Sonsini Goodrich & Rosati, the Medical Device Manufacturers Association (MDMA) provided the FDA with a number of examples of how current FDA policies and practices hamper innovation by creating unnecessary burdens on companies trying to innovate. In response, the FDA asked the MDMA to generate data to support the industry’s concerns. As a result, the MDMA, in conjunction with the National Venture Capital Association, Dr. Josh Makower, and Aabed Meer, developed a survey and deployed it to the MDMA’s members—amounting to more than 200 smalland medium-sized medical technology companies—to quantify the impact that the FDA is having on the medical device industry. Of particular interest, the study reported the following...

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Wilson Sonsini Goodrich & Rosati | Attorney Advertising

Written by:


Wilson Sonsini Goodrich & Rosati on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.